SNRPGP7

Across TCGA pan-cancer cohorts, SNRPGP7 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated SNRPGP7 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNRPGP7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNRPGP7 expression acts as an unfavorable survival marker.

KIRC, DLBC, and BLCA are the cancer types where SNRPGP7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.349	0.806	<.001	66	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	54	view →
BLCA	OS	Tertile	IV	0.132	0.604	<.001	42	view →
TGCT	DFS	Tertile	All	0.453	0.850	.001	36	view →
HNSC	OS	Tertile	III,IV	0.138	0.674	.015	36	view →
BRCA	OS	Tertile	II,III,IV	0.711	0.915	.007	27	view →
COAD	OS	Tertile	III,IV	0.110	0.587	<.001	24	view →
MESO	OS	Tertile	III,IV	0.130	0.579	.033	18	view →
READ	DFS	Tertile	III,IV	0.222	0.763	.005	18	view →
LGG	OS	Tertile	All	0.705	0.893	.004	12	view →
KIRP	OS	Tertile	III,IV	0.178	0.660	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

SNRPGP7–KIRC (DFS)

Open the KIRC breakdown →